128
Views
2
CrossRef citations to date
0
Altmetric
Commentary

Why Are Children With Bronchiolitis At Risk Of Urinary Tract Infections?

Pages 251-254 | Published online: 14 Nov 2019

Abstract

Viral respiratory infections are frequently eliminated from human bodies without any sequelae. Secondary serious bacterial infection (SBI) in children with acute bronchiolitis has been an apprehension expressed by health care providers. Several published studies have shown an association between acute bronchiolitis and secondary bacterial infection, including urinary tract infections (UTI). However, the proposed mechanism by which a virus can induce UTIs is not yet known. The aim of this commentary is to update the current evidence of risk of UTI in children with bronchiolitis. We present several clinical studies related to the topic as well as a brief review of the potential pathophysiology of secondary infections that could present with viral respiratory illness.

Review Of The Literature

Viral respiratory infections are frequently eliminated from human bodies without any sequelae. Nevertheless, in some occasions viruses can evade the immune reaction of the airways, leading to austere respiratory diseases.Citation1 Potent mechanical and immunosuppressive methods protect the lungs against external infections, but a solitary respiratory tract infection can change immunity and pathology.Citation2 Secondary serious bacterial infection (SBI) in children with acute bronchiolitis has been an apprehension expressed by health care providers.Citation3 Several published studies have shown an association between acute bronchiolitis and secondary bacterial infection, including urinary tract infections (UTI).Citation4Citation13 However, the proposed mechanism by which a virus can induce UTIs is not yet known.

In a review of the literature, the percentage of patients with fever with positive urine cultures ranged from 4.2% to 20.0% in infants <3 months of age and 0% to 7.4% in older children (3 to 36 months of age).Citation14 Ralston et alCitation3 conducted a systematic review delineating the risk of occult SBI in young febrile infants presenting with either “clinical bronchiolitis” or “proven RSV infection”. The review included 11 studies.Citation4Citation7,Citation9Citation13,Citation15,Citation16 The rate of urinary tract infections in the 11 studies analyzed was 3.3% (95% confidence interval, 1.9–5.7%). The authors concluded the rate of urine cultures positive for bacteria was noteworthy, though asymptomatic bacteriuria may have muddled the results. Recently, McDaniel et alCitation17 conducted a systematic review and meta-analysis exploring the prevalence of UTI in infants and young children with bronchiolitis when positive urinalysis (UA) results being incorporated into the UTI definition. The investigators included 18 studies,Citation4Citation7,Citation9,Citation11Citation13,Citation15,Citation16,Citation18Citation25 seven of which had UA information.Citation4,Citation11,Citation16,Citation18,Citation20Citation22 The definition of positive UA varied among the studies. Some considered positive UA as having more than 5 white blood cells per high-powered field, while others considered the UA positive by having bacteriuria, positive leukocyte esterase, or positive nitrite. The prevalence of UTI in bronchiolitis in the 18 studies was 3.1% (95% CI, 1.8–4.6%). The authors further analyzed the data of the 7 studies where the presence of pyuria or nitrites was a diagnostic criterion to define UTI and the prevalence of UTI was 0.8% (95% CI, 0.3–1.4%).

However, the above studies did not sub-categorize the prevalence of UTI in bronchiolitis per specific respiratory virus as a trigger. Hendaus et alCitation8 studied the prevalence of urinary tract infection in infants and children with bronchiolitis. The study included 835 pediatric patients with acute bronchiolitis. The mean (±SD) age at diagnosis was 3.47±2.99 months. There were 325 (39%) girls and 510 (61%) boys. Participants were divided into three groups: group 1 comprised of children hospitalized with bronchiolitis and a positive diagnosis for respiratory syncytial virus (RSV) bronchiolitis; group 2 comprised of children hospitalized with clinical bronchiolitis with no virus detected; and group 3 comprised of children hospitalized with clinical with bronchiolitis and a positive diagnosis respiratory virus other than RSV. After applying inclusion and exclusion criteria, RSV was notorious in 352 (45.7%) patients; respiratory viruses other than RSV were identified in 275 (35.7%) patients and 142 (18.4%) were studied but had no viruses detected. Non-RSV viruses comprised of rhinovirus (n=85 [31%]), parainfluenza virus type 4 (n=40 [14%]), adenovirus (n=40 [14%]), human metapneumovirus (HMPV) (n=27 [10%]), bocavirus (n=27 [10%]), coronavirus (n=20 [7%]), parainfluenza virus (hPIV) type 1 (n=9 [3.4%]), hPIV type 2 (n=9 [3.4%]), hPIV type 3 (n=9 [3.4%]), and H1N1pdm09 (n=9 [3.4%]). The definition of UTI was adopted from the American Academy of Pediatrics as

clinicians should require both urinalysis results that suggest infection (pyuria and/or bacteriuria) and the presence of ≥50,000 colony-forming units (CFUs) per milliliter of a uropathogen cultured from a urine specimen obtained through catheterization or suprapubic aspirate.Citation26

The overall prevalence of UTI was 10%, and was most common in group 3 (13.4%) trailed by group 2 (9.7%), and was least common in group 1 (6%) (P=0.030). The most reasonable explanation of why the rate of UTI was higher in the study conducted by Hendaus et alCitation8 was because it was the first published study that sub-categorized the prevalence of UTI in bronchiolitis per specific respiratory virus as a trigger.

So What Could Be The Potential Pathophysiology?

The epithelium is usually protected by a layer of mucus that functions as a border.Citation27Citation29 Viruses can inflict impairment on host epithelial cells, and mammalian cells are susceptible to bacterial attachment during a viral sickness.Citation30 Moreover, viruses can incapacitate the mucociliary clearance arrangement, causing increased attachment of bacteria to mucins and colonization.Citation31 Viruses like the influenza and RSV might injure ciliated cells, causing ciliostasis, and hence worsening of mucociliary clearance.Citation30,Citation32,Citation33 Furthermore, virus-induced cell demise weakens the mechanical elimination of the close pathogens and exhibits new receptors for bacterial adherence.Citation34 The respiratory virus-infected epithelia enable the attraction of inflammatory cells, including natural killer cells, neutrophils, macrophages, and eosinophils from the bloodstream into the infected area.Citation35

The epithelium identifies microorganisms through pattern recognition receptors, such as nucleotide-binding oligomerization domain (NOD)-like receptors (NLRs), retinoic acid-inducible gene (RIG)-like helicases,Citation36,Citation37 and Toll-like receptors (TLRs).Citation29 NLRs and RIG-like helicases activate innate immune reactions through cytosolic detection of viral and bacterial components,Citation37,Citation38 while TLRs are single, noncatalytic, membrane-spanning receptor proteins utilized by the innate immune system.Citation39 Post-viral continued desensitization of lung sentinel cells to TLR signals might contribute to secondary bacterial infection. For instance, TLR4 and TLR5 pathways are modified after influenza virus infection, leading to decreased neutrophil attraction, hence resulting in increased attachment of bacteria.Citation38

Several epithelial cells can also express the classical antiviral interferons (INFs), especially IFN-α and IFN-β.Citation40,Citation41 The link between host cells and microorganisms during sickness prompts immune reaction that comprise the generation of pro-inflammatory molecules. In spite of their important role as a bactericidal, pro-inflammatory cytokines such as TNF-α produced in response to infection could be injurious to the host cells.Citation42 Viruses can also have an impact in modulating many molecules such as intercellular adhesion molecule 1 (ICAM-1), carcinoembryonic antigen-related cellular adhesion 1 (CEACAM-1), and platelet-activating factor receptor (PAF-r),Citation43 resulting in a risk of bacterial adherence.Citation44

Throughout a viral episode, TLR and RIG-I-like receptor activation prompts fabrication of type I IFNs, which can then boost the inflammatory response to TLR ligands including lipopolysaccharide (LPS).Citation45,Citation46 Interface between type I IFNs and Nod1/Nod2 signalling results in bacterial recognition, and causes damaging effects in the virally infected host.Citation47

Conclusions And Recommendations

  1. Published studies do not robustly support the idea that viral bronchiolitis can lead to bacterial UTI.

  2. Despite the fact that a viral infection can lead to secondary bacterial infection, the mechanism of acquiring UTI after viral bronchiolitis is not very well known.

  3. Large randomized studies are required to tackle the possible causation/association (bronchiolitis vs UTI).

  4. Performing urine microscopy and urine culture on a febrile young child with bronchiolitis should be individualized per patient’s condition.

Acknowledgment

Publication of this manuscript has been funded by Qatar National Library.

Disclosure

The author reports no conflicts of interest in this work.

References

  • Vareille M, Kieninger E, Edwards MR, Regamey N. The airway epithelium: soldier in the fight against respiratory viruses. Clin Microbiol Rev. 2011;24(1):210–229. doi:10.1128/CMR.00014-1021233513
  • Walzl G, Tafuro S, Moss P, Openshaw PJ, Hussell T. Influenza virus lung infection protects from respiratory syncytial virus-induced immunopathology. J Exp Med. 2000;192(9):1317–1326. doi:10.1084/jem.192.9.131711067880
  • Ralston S, Hill V, Waters A. Occult serious bacterial infection in infants younger than 60 to 90 days with bronchiolitis: a systematic review. Arch Pediatr Adolesc Med. 2011;165:951–956. doi:10.1001/archpediatrics.2011.15521969396
  • Melendez E, Harper MB. Utility of sepsis evaluation in infants 90 days of age or younger with fever and clinical bronchiolitis. Pediatr Infect Dis J. 2003;22:1053–1056. doi:10.1097/01.inf.0000101296.68993.4d14688564
  • Levine DA, Platt SL, Dayan PS, et al. Multicenter RSV-SBI Study Group of the Pediatric Emergency Medicine Collaborative Research Committee of the American Academy of Pediatrics Risk of serious bacterial infection in young febrile infants with respiratory syncytial virus infections. Pediatrics. 2004;113:1728–1734. doi:10.1542/peds.113.6.172815173498
  • Purcell K, Fergie J. Concurrent serious bacterial infections in 2396 infants and children hospitalized with respiratory syncytial virus lower respiratory tract infections. Arch Pediatr Adolesc Med. 2002;156:322–324. doi:10.1001/archpedi.156.4.32211929363
  • Titus MO, Wright SW. Prevalence of serious bacterial infections in febrile infants with respiratory syncytial virus infection. Pediatrics 2003;112:282–284. doi:10.1542/peds.112.2.28212897274
  • Hendaus MA, Alhammadi AH, Khalifa MS, Muneer E, Chandra P. Risk of urinary tract infection in infants and children with acute bronchiolitis. Paediatr Child Health. 2015;20(5):e25–e29. doi:10.1093/pch/20.5.e2526175566
  • Oray-Schrom P, Phoenix C, St Martin D, Amoateng-Adjepong Y. Sepsis workup in febrile infants 0–90 days of age with respiratory syncytial virus infection. Pediatr Emerg Care. 2003;19:314–319. doi:10.1097/01.pec.0000092576.40174.2814578830
  • Byington CL, Enriquez FR, Hoff C, et al. Serious bacterial infections in febrile infants 1 to 90 days old with and without viral infections. Pediatrics 2004;113:1662–1666. doi:10.1542/peds.113.6.166215173488
  • Antonow JA, Hansen K, McKinstry CA, Byington CL. Sepsis evaluations in hospitalized infants with bronchiolitis. Pediatr Infect Dis J. 1998;17:231–236. doi:10.1097/00006454-199803000-000119535251
  • Bilavsky E, Shouval DS, Yarden-Bilavsky H, Fisch N, Ashkenazi S, Amir J. A prospective study of the risk for serious bacterial infections in hospitalized febrile infants with or without bronchiolitis. Pediatr Infect Dis J. 2008;27:269–270. doi:10.1097/INF.0b013e31815e85b118277919
  • Kuppermann N, Bank DE, Walton EA, Senac MO Jr, McCaslin I. Risks for bacteremia and urinary tract infections in young febrile children with bronchiolitis. Arch Pediatr Adolesc Med. 1997;151:1207–1214. doi:10.1001/archpedi.1997.021704900330069412595
  • Baraff LJ, Bass JW, Fleisher GR, et al. Practice guideline for the management of infants and children 0 to 36 months of age with fever without source. Pediatrics. 1993;92:1–12.
  • Liebelt EL, Qi K, Harvey K. Diagnostic testing for serious bacterial infections in infants aged 90 days or younger with bronchiolitis. Arch Pediatr Adolesc Med. 1999;153:525–530. doi:10.1001/archpedi.153.5.52510323635
  • Luginbuhl LM, Newman TB, Pantell RH, Finch SA, Wasserman RC. Office-based treatment and outcomes for febrile infants with clinically diagnosed bronchiolitis. Pediatrics 2008;122:947–954. doi:10.1542/peds.2007-320618977972
  • McDaniel CE, Ralston S, Lucas B, Schroeder AR. Association of diagnostic criteria with urinary tract infection prevalence in bronchiolitis: a systematic review and meta-analysis. JAMA Pediatr. 2019. doi:10.1001/jamapediatrics.2018.5091.
  • Elkhunovich MA, Wang VJ. Assessing the utility of urine testing in febrile infants aged 2 to 12months with bronchiolitis. Pediatr Emerg Care. 2015;31(9):616–620. doi:10.1097/PEC.000000000000035925834961
  • Purcell K, Fergie J. Concurrent serious bacterial infections in 912 infants and children hospitalized for treatment of respiratory syncytial virus lower respiratory tract infection. Pediatr Infect Dis J. 2004;23(3):267–269. doi:10.1097/01.inf.0000116759.21252.2915014307
  • Kaluarachchi D, Kaldas V, Roques E, Nunez R, Mendez M. Comparison of urinary tract infection rates among 2- to 12-month-old febrile infants with RSV infections using 1999 and 2011 AAP diagnostic criteria. Clin Pediatr (Phila). 2014;53(8):742–746. doi:10.1177/000992281452901524681546
  • Randolph AG, Reder L, Englund JA. Risk of bacterial infection in previously healthy respiratory syncytial virus-infected young children admitted to the intensive care unit. Pediatr Infect Dis J. 2004;23(11):990–994. doi:10.1097/01.inf.0000143647.88873.6615545852
  • Schlechter Salinas AK, Hains DS, Jones T, Harrell C, Meredith M. Testing for urinary tract infection in the influenza/respiratory syncytial virus-positive febrile infant aged 2 to 12 months. Pediatr Emerg Care. 2017. doi:10.1097/PEC.0000000000001073
  • Yarden-Bilavsky H, Ashkenazi-Hoffnung L, Livni G, Amir J, Bilavsky E. Month-by-month age analysis of the risk for serious bacterial infections in febrile infants with bronchiolitis. Clin Pediatr (Phila). 2011;50(11):1052–1056. doi:10.1177/000992281141294921685212
  • García CG, Bhore R, Soriano-Fallas A, et al. Risk factors in children hospitalized with RSV bronchiolitis versus non-RSV bronchiolitis. Pediatrics. 2010;126(6):e1453–e1460. doi:10.1542/peds.2010-050721098154
  • Librizzi J, McCulloh R, Koehn K, Alverson B. Appropriateness of testing for serious bacterial infection in children hospitalized with bronchiolitis. Hosp Pediatr. 2014;4(1):33–38. doi:10.1542/hpeds.2013-007324435599
  • Roberts KB, American Academy of Pediatrics, Subcommittee on Urinary Tract Infection, Steering Committee on Quality Improvement and Management. Urinary tract infection: clincal practice guideline for diagnosis and management of the initial UTI in febrile infants and children 2 to 24 months. Pediatrics. 2011;128:595–610.21873693
  • Voynow JA, Rubin BK. Mucins, mucus, and sputum. Chest. 2009;135(2):505–512. doi:10.1378/chest.08-041219201713
  • Thornton DJ, Rousseau K, McGuckin MA. Structure and function of the polymeric mucins in airways mucus. Annu Rev Physiol. 2008;70:459–486. doi:10.1146/annurev.physiol.70.113006.10070217850213
  • Rose MC, Voynow JA. Respiratory tract mucin genes and mucin glycoproteins in health and disease. Physiol Rev. 2006;86(1):245–278. doi:10.1152/physrev.00010.200516371599
  • Pittet LA, Hall-Stoodley L, Rutkowski MR, Harmsen AG. Influenza virus infection decrease stracheal mucociliary velocity and clearance of Streptococcus pneumoniae. Am J Respir Cell Mol Biol. 2010;42(4):450–460. doi:10.1165/rcmb.2007-0417OC19520922
  • Wilson R, Dowling RB, Jackson AD. The biology of bacterial-colonization and invasion of the respiratory mucosa. Eur Respir J. 1996;9(7):1523–1530. doi:10.1183/09031936.96.090715238836669
  • Tristram DA, Hicks W Jr, Hard R. Respiratory syncytial virus and human bronchial epithelium. Arch Otolaryngol Head Neck Surg. 1998;124:777–783. doi:10.1001/archotol.124.7.7779677113
  • McCullers JA, Iverson AR, McKeon R, Murray PJ. The platelet activating factor receptor is not required for exacerbation of bacterial pneumonia following influenza. Scand J Infect Dis. 2008;40(1):11–17. doi:10.1080/0036554070147756817852951
  • Bragonzi A, Copreni E, de Bentzmann S, Ulrich M, Conese M. Airway epithelial cell-pathogen interactions. J Cyst Fibros. 2004;3(suppl 2):197–201. doi:10.1016/j.jcf.2004.05.041
  • Katze MG, He Y, Gale M Jr. Viruses and interferon: a fight for supremacy. Nat Rev Immunol. 2002;2(9):675–687. doi:10.1038/nri88812209136
  • Akira S. Pathogen recognition by innate immunity and its signaling. Proc Jpn Acad Ser B Phys Biol Sci. 2009;85(4):143–156. doi:10.2183/pjab.85.143
  • Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell 2006;124:783–801. doi:10.1016/j.cell.2006.02.01516497588
  • Didierlaurent A, Goulding J, Patel S, et al. Sustained desensitization to bacterial Toll-like receptor ligands after resolution of respiratory influenza infection. J Exp Med. 2008;205(2):323–329. doi:10.1084/jem.2007089118227219
  • Kanneganti TD, Lamkanfi M, Nunez G. Intracellular NOD-like receptors in host defense and disease. Immunity 2007;27:549–559. doi:10.1016/j.immuni.2007.10.00217967410
  • Inohara N, Ogura Y, Fontalba A, et al. Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn’s disease. J Biol Chem. 2003;278:5509–5512.12514169
  • Basler CF, García-Sastre A. Viruses and the type I interferon antiviral system: induction and evasion. Int Rev Immunol. 2002;21(4–5):305–337. doi:10.1080/0883018021327712486817
  • Cook DN, Pisetsky DS, Schwartz DA. Toll-like receptors in the pathogenesis of human disease. Nat Immunol. 2004;5:975–979. doi:10.1038/ni111615454920
  • Message SD, Johnston SL. Host defense function of the airway epithelium in health and disease: clinical background. J Leukoc Biol. 2004;75(1):5–17. doi:10.1189/jlb.070331512972516
  • Ishizuka S, Yamaya M, Suzuki T, et al. Effects of rhinovirus infection on the adherence of Streptococcus pneumoniae to cultured human airway epithelial cells. J Infect Dis. 2003;188(12):1928–1939. doi:10.1086/jid.2003.188.issue-1214673774
  • Nansen A, Randrup Thomsen A. Viral infection causes rapid sensitization to lipopolysaccharide: central role of IFN-alpha beta. J Immunol. 2001;166:982–988. doi:10.4049/jimmunol.166.2.98211145676
  • Doughty L, Nguyen K, Durbin J, Biron C. A role for IFN-alpha beta in virus infection-induced sensitization to endotoxin. J Immunol. 2001;166:2658–2664. doi:10.4049/jimmunol.166.4.265811160329
  • Kim YG, Park JH, Reimer T, et al. Viral infection augments Nod1/2 signaling to potentiate lethality. Cell Host Microbe. 2011;9(6):496–507. doi:10.1016/j.chom.2011.05.00621669398